A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

Ursula A. Matulonis, Ronnie Shapira‐Frommer, Alessandro D. Santin et al. · Annals of Oncology · 2019 · 840 citations · Full text

Medicine, Oncology, Pharmacology +15

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller et al. · The Lancet Oncology · 2019 · 537 citations

Medicine, Oncology, Pharmacotherapy +10

Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer

Weimin Wang, Ilona Kryczek, Lubomír Dostál et al. · Cell · 2016 · 432 citations · Full text

Medicine, Immunology, Oncology +12

Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins

Yong Yu, Shahrokh Shabahang, Tatyana M. Timiryasova et al. · Nature Biotechnology · 2004 · 426 citations

Medicine, Cancer Biology, Molecular Biology +16

Eradication of Solid Human Breast Tumors in Nude Mice with an Intravenously Injected Light-Emitting Oncolytic Vaccinia Virus

Qian Zhang, Yong Yu, Ena Wang et al. · Cancer Research · 2007 · 230 citations · Full text

Life Sciences, Molecular Biology, Oncology +14